Cure My Disease

Don't miss your cure!

 Log in / Sign up

New injectable drug shows promise for schizophrenia relapse

NCT ID NCT05480046

Completed Disease control Sponsor: Rovi Pharmaceuticals Laboratories Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 15, 2026 · Updated 18 times

Summary

This study looked at how well Risperidone ISM works in real-world settings for people with schizophrenia who were hospitalized after a relapse. Researchers tracked 275 patients over 56 days to see if their symptoms and daily functioning improved. The goal was to understand the drug's effectiveness and safety when used in routine hospital care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational Site number DE-01

    Essen, Germany

  • Investigational site number DE-02

    Chemnitz, Germany

  • Investigational site number DE-03

    Dortmund, Germany

  • Investigational site number DE-04

    Munich, Germany

  • Investigational site number DE-05

    Mannheim, Germany

  • Investigational site number DE-06

    Aachen, Germany

  • Investigational site number DE-07

    Bonn, Germany

  • Investigational site number DE-08

    Greifswald, Germany

  • Investigational site number DE-09

    München, Germany

  • Investigational site number DE-10

    Berlin, Germany

  • Investigational site number DE-12

    Berlin, Germany

  • Investigational site number DE-13

    Werneck, Germany

  • Investigational site number DE-14

    Ansbach, Germany

  • Investigational site number DE-15

    Berlin, Germany

  • Investigational site number DE-16

    Bonn, Germany

  • Investigational site number DE-19

    Leipzig, Germany

  • Investigational site number DE-20

    Hemer, Germany

  • Investigational site number DE-22

    Hamburg, Germany

  • Investigational site number DE-23

    Bayreuth, Germany

  • Investigational site number DE-24

    Neustadt, Germany

  • Investigational site number DE-25

    Eberswalde, Germany

  • Investigational site number ES-02

    Talavera de la Reina, Spain

  • Investigational site number ES-03

    Barcelona, Spain

  • Investigational site number ES-04

    Manacor, Spain

  • Investigational site number ES-11

    Granada, Spain

  • Investigational site number ES-14

    Móstoles, Spain

  • Investigational site number ES-16

    Burgos, Spain

  • Investigational site number ES-18

    Murcia, Spain

  • Investigational site number ES-19

    Madrid, Spain

  • Investigational site number ES-21

    Jaén, Spain

  • Investigational site number ES-23

    Córdoba, Spain

  • Investigational site number ES-24

    Madrid, Spain

  • Investigational site number ES-31

    Vigo, Spain

  • Investigational site number ES-40

    Vitoria-Gasteiz, Spain

  • Investigational site number ES-42

    Torrejón, Spain

  • Investigational site number ES-45

    Barcelona, Spain

  • Investigational site number ES-49

    Lleida, Spain

  • Investigational site number ES-51

    Lugo, Spain

  • Investigational site number ES-52

    Ourense, Spain

  • Investigational site number ES-59

    Huesca, Spain

  • Investigational site number ES-60

    Las Palmas de Gran Canaria, Spain

  • Investigational site number ES-62

    Ponferrada, Spain

  • Investigational site number ES-63

    Majadahonda, Spain

  • Investigational site number ES-65

    Mataró, Spain

  • Investigational site number ES-66

    Madrid, Spain

  • Investigational site number ES-69

    Santander, Spain

  • Investigational site number ES-70

    Jerez de la Frontera, Spain

  • Investigational site number ES-72

    L'Hospitalet de Llobregat, Spain

  • Investigational site number ES-73

    Manresa, Spain

  • Investigational site number ES-76

    Úbeda, Spain

  • Investigational site number ES-81

    Barcelona, Spain

  • Investigational site number GB-08

    London, United Kingdom

  • Investigational site number IT-03

    Legnano, Italy

  • Investigational site number IT-06

    Milan, Italy

  • Investigational site number IT-113

    Palermo, Italy

  • Investigational site number IT-18

    Montichiari, Italy

  • Investigational site number IT-19

    Bolzano, Italy

  • Investigational site number IT-20

    Crema, Italy

  • Investigational site number IT-24

    Brescia, Italy

  • Investigational site number IT-32

    Ancona, Italy

  • Investigational site number IT-41

    Foggia, Italy

  • Investigational site number IT-42

    Milan, Italy

  • Investigational site number IT-44

    Putignano, Italy

  • Investigational site number IT-47

    Manfredonia, Italy

  • Investigational site number IT-65

    Brindisi, Italy

  • Investigational site number IT-90

    Vimercate, Italy

  • Investigational site number IT-97

    Sant'Agata di Militello, Italy

  • Investigational site number PT-01

    Coimbra, Portugal

  • Investigational site number PT-11

    Santo Tirso, Portugal

  • Investigational site number PT-13

    Porto, Portugal

  • Investigational site number PT-20

    Guarda, Portugal

  • Investigational site number PT-24

    Braga, Portugal

  • Investigational site number PT-25

    Beja, Portugal

  • Investigational site number PT-27

    Tomar, Portugal

  • Investigational site number PT-32

    Portimão, Portugal

  • Investigational site number PT-33

    Funchal, Portugal

  • Investigational site number PT-36

    Funchal, Portugal

Conditions

Explore the condition pages connected to this study.

SCHIZOPHRENIA